Clearside Biomedical, Inc. (CLSDQ) SEC Filings — 2025
19 SEC filings for Clearside Biomedical, Inc. (CLSDQ) in 2025.
Filings
- Clearside Biomedical, Inc. 8-K Filing — 8-K · Dec 29, 2025
- Clearside Biomedical Faces Delisting Notice — 8-K · Dec 8, 2025
- Clearside Biomedical Files 8-K Amid Listing Concerns — 8-K · Nov 25, 2025
- Clearside's Cash Dwindles Amid Strategic Review, R&D Pause — 10-Q · Nov 14, 2025
- Clearside Biomedical Files 8-K for Other Events — 8-K · Oct 7, 2025
- Clearside Biomedical Files 8-K with Corporate Updates — 8-K · Sep 11, 2025
- Clearside Biomedical Changes Fiscal Year End — 8-K · Sep 11, 2025
- Clearside Biomedical Enters Material Definitive Agreement — 8-K · Sep 8, 2025
- Clearside Biomedical Files 8-K on Delisting and Shareholder Vote — 8-K · Sep 3, 2025
- Clearside Biomedical Faces Delisting Concerns — 8-K · Aug 14, 2025
- Clearside Narrows Q2 Loss Amidst Revenue Dip, R&D Cuts — 10-Q · Aug 8, 2025
- Clearside Biomedical Proposes 1-for-5 to 1-for-15 Reverse Stock Split — DEF 14A · Aug 4, 2025
- Clearside Biomedical Files 8-K on Executive Changes & Costs — 8-K · Jul 17, 2025
- Clearside Biomedical Files 8-K with Corporate Updates — 8-K · May 30, 2025
- Clearside Biomedical Files Q1 2025 10-Q — 10-Q · May 15, 2025
- Clearside Biomedical Files 8-K on Financials — 8-K · May 14, 2025
- Clearside Biomedical Files 2024 Executive Compensation Details — DEF 14A · Apr 18, 2025
- Clearside Biomedical Files 2024 10-K — 10-K · Mar 27, 2025
- Clearside Biomedical Faces Nasdaq Delisting Warning — 8-K · Feb 13, 2025